Form 8-K - Current report:
SEC Accession No. 0001279569-25-000595
Filing Date
2025-06-10
Accepted
2025-06-10 17:30:54
Documents
12
Period of Report
2025-06-09
Items
Item 1.03: Bankruptcy or Receivership

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 25242
  Complete submission text file 0001279569-25-000595.txt   187015

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20250609.xsd EX-101.SCH 3093
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20250609_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20250609_pre.xml EX-101.PRE 22371
15 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3470
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 251038203
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)